Report #2841381

Received May 16, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: NC
Recovered: Not recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Headache

Symptom narrative

has had a headache on and off for over 3 days; This non-serious case was reported by a nurse via sales rep and described the occurrence of headache in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced headache (Verbatim: has had a headache on and off for over 3 days). The outcome of the headache was resolving. The reporter considered the headache to be related to Shingrix. The company considered the headache to be related to Shingrix. Additional Information: GSK Receipt Date: 08-MAY-2025 The reporter mentioned that patient had a headache on and off for over 3 days since vaccine administration.